CRISPR Therapeutics AG Human Resources Contracts & Agreements
26 Contracts & Agreements
- Bonus & Incentive Agreements (16 contracts)
- Consulting Agreements (1)
- Employment Agreements (8)
- Retirement Agreements (1)
- Employment Agreement, dated May 23, 2022, by and between CRISPR Therapeutics AG and Phuong Khanh Morrow (Filed With SEC on August 8, 2022)
- Employment Agreement, dated October 14, 2021, by and between CRISPR Therapeutics, Inc. and Brendan Smith (Filed With SEC on October 14, 2021)
- Retirement Agreement, dated December 13, 2019, among Casebia Therapeutics Limited Liability Partnership, Bayer HealthCare LLC, CRISPR Therapeutics AG and CRISPR Therapeutics, Inc (Filed With SEC on February 12, 2020)
- Mandate Agreement, dated December 27, 2019, by and between CRISPR Therapeutics AG and Oriolus Consulting LLC (Filed With SEC on December 27, 2019)
- Senior Executive Cash Incentive Bonus Plan (Filed With SEC on March 8, 2018)
- Form of Restricted Stock Award Agreement for Non-Employee Directors under CRISPR Therapeutics AGs 2018 Stock Option and Incentive Plan (Filed With SEC on March 8, 2018)
- Form of Restricted Stock Award Agreement for Company Employees under CRISPR Therapeutics AGs 2018 Stock Option and Incentive Plan (Filed With SEC on March 8, 2018)
- Form of Restricted Stock Award Agreement under CRISPR Therapeutics AGs 2018 Stock Option and Incentive Plan (Filed With SEC on March 8, 2018)
- Form of Non-Qualified Stock Option Agreement for Non-Employee Directors under CRISPR Therapeutics AGs 2018 Stock Option and Incentive Plan (Filed With SEC on March 8, 2018)
- Form of Non-Qualified Stock Option Agreement for Company Employees under CRISPR Therapeutics AGs 2018 Stock Option and Incentive Plan (Filed With SEC on March 8, 2018)
- Form of Incentive Stock Option Agreement under CRISPR Therapeutics AGs 2018 Stock Option and Incentive Plan (Filed With SEC on March 8, 2018)
- CRISPR Therapeutics AG 2018 Stock Option and Incentive Plan (Filed With SEC on March 8, 2018)
- Employment Agreement, dated August 1, 2017, by and between CRISPR Therapeutics, Inc. and Tony Ho (Filed With SEC on March 8, 2018)
- Employment Agreement, dated May 31, 2017, by and between CRISPR Therapeutics, Inc. and James R. Kasinger (Filed With SEC on March 8, 2018)
- Employment Agreement, dated November 13, 2017, by and between CRISPR Therapeutics, Inc. and Michael Tomsicek (Filed With SEC on March 8, 2018)
- Employment Agreement by and between CRISPR Therapeutics AG and Dr. Rodger Novak, dated as of December 20, 2017 (Filed With SEC on December 21, 2017)
- Form of Restricted Stock Award Agreement for Non-Employee Directors under CRISPR Therapeutics AGs Amended and Restated 2016 Stock Option and Incentive Plan (Filed With SEC on November 8, 2017)
- Form of Restricted Stock Award Agreement for Company Employees under Registrants Amended and Restated 2016 Stock Option and Incentive Plan (Filed With SEC on November 8, 2017)
- Form of Restricted Stock Award Agreement under CRISPR Therapeutics AGs Amended and Restated 2016 Stock Option and Incentive Plan (Filed With SEC on November 8, 2017)
- Form of Non-Qualified Stock Option Agreement for Non-Employee Directors under CRISPR Therapeutics AGs Amended and Restated 2016 Stock Option and Incentive Plan (Filed With SEC on November 8, 2017)
- Form of Non-Qualified Stock Option Agreement for Company Employees under Registrants Amended and Restated 2016 Stock Option and Incentive Plan (Filed With SEC on November 8, 2017)
- Form of Incentive Stock Option Agreement under CRISPR Therapeutics AGs Amended and Restated 2016 Stock Option and Incentive Plan (Filed With SEC on November 8, 2017)
- Second Amended and Restated Employment Agreement, dated October 2, 2017, by and between CRISPR Therapeutics, Inc. and Samarth Kulkarni (Filed With SEC on October 2, 2017)
- CRISPR THERAPEUTICS AG AMENDED AND RESTATED 2016 STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on June 2, 2017)
- AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on May 4, 2017)
- CRISPR THERAPEUTICS AG 2016 STOCK OPTION AND INCENTIVE PLAN1 (Filed With SEC on September 9, 2016)
